Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,609 | -5,611 | -3,510 | -18,600 | -10,730 |
| Depreciation Amortization | 149 | 98 | 49 | 186 | 132 |
| Accounts receivable | -107 | -19 | 73 | -40 | -23 |
| Other Working Capital | -302 | -444 | 410 | -3,073 | -1,697 |
| Other Operating Activity | 1,245 | 1,007 | 723 | 5,944 | 781 |
| Operating Cash Flow | $-6,625 | $-4,969 | $-2,256 | $-15,584 | $-11,537 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -128 | N/A | N/A | -39 | -39 |
| Net Acquisitions | -500 | -500 | N/A | -209 | 92 |
| Other Investing Activity | 0 | 0 | 0 | -425 | 0 |
| Investing Cash Flow | $-628 | $-500 | $0 | $-673 | $53 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -291 | -262 |
| Common Stock Issued | 10,681 | 10,744 | 6,000 | 17,146 | 12,000 |
| Other Financing Activity | 0 | 0 | -571 | -1,785 | -1,719 |
| Financing Cash Flow | $10,681 | $10,744 | $5,429 | $15,071 | $10,019 |
| Beginning Cash Position | 6,177 | 6,177 | 6,177 | 7,363 | 7,363 |
| End Cash Position | 9,604 | 11,453 | 9,350 | 6,177 | 5,898 |
| Net Cash Flow | $3,427 | $5,276 | $3,174 | $-1,186 | $-1,465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,625 | -4,969 | -2,256 | -15,584 | -11,537 |
| Capital Expenditure | -128 | N/A | N/A | -39 | -39 |
| Free Cash Flow | -6,754 | -4,969 | -2,256 | -15,623 | -11,576 |